KEA clinical trial involving children with sickle cell disease has resulted in deaths in several countries, including Kenya. Sickle cell disease is a genetic disorder affecting red blood cells, leading to severe pain and complications. Trials aim to find new treatments or cures, but they carry risks, especially for vulnerable populations like children. Reports indicate that some participants in these trials have succumbed to their conditions or complications arising from the treatment. This has raised concerns about the safety protocols and ethical considerations in such medical research.
Bias read (Center): The article reports on a medical trial with fatalities, which is primarily a health issue. However, since it involves government-regulated medical research and raises questions about national healthcare policies and oversight, it enters the realm of politics. The article does not exhibit clear bias,
